Browse > Article

Issues of Conflict of Interest in Psychiatric Research and Practice  

Shin, Eun-Hee (Department of Nursing, College of Health Sciences, Sangji University)
Lim, Se-Won (Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
Publication Information
Anxiety and mood / v.11, no.2, 2015 , pp. 114-119 More about this Journal
Abstract
A conflict of interest is usually defined as a set of circumstances that creates a risk that professional judgments or actions regarding a primary interest will be unduly influenced by a secondary interest. In general, a conflict of interest can be classified as either a financial or a non-financial one. A financial conflict of interest reportedly occurs frequently in medical (and psychiatric) research and practice and is associated with a greater likelihood of reporting results favorable to the intervention being studied. A non-financial conflict of interest may occur in psychiatric research and practice as a result of the so-called "allegiance effect." It is very important that clinicians and researchers in the field of psychiatry be aware that their field is vulnerable to both financial and non-financial conflicts of interest. Considering that it is impossible in modern psychiatry to be completely free from possible conflicts of interest, the best way to manage a conflict of interest is disclosure based on the principles of transparency. Actions that might lead to conflicts of interest should be avoided as much as possible.
Keywords
Conflict of interest; Psychiatry; Clinical Practice; Research;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Macrina FD. Scientific Integrity. Washington DC: ASM Press 2005:165.
2 Thompson DF. Understanding financial conflicts of interest. N Engl J Med 1993;329:573-576.   DOI
3 Maj M. Conflicts of interests in psychiatric practice and research. Psychiatric 2005;3 138-140.
4 Perlis RG, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005;162:1957-1960.   DOI
5 Fava GA. Financial conflicts of interest in psychiatry. World Psychiatry 2007;6: 19-24.
6 Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine. and quetiapine beats olanzapine: an exploratory analysis of head -to-head comparison studies of second-generation anti psychotics. Am J Psychiatry 2006;163:185-194.   DOI
7 Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW. Quantitativeanalysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003:183:498-506.   DOI
8 Steinbrook R. Controlling conflict of interest: proposals from the Institute of Medicine. N Engl J Med 2009;360:2160-2163.   DOI
9 Lee IK, Koo YM. Ethical principles in physician-pharmaceutical industry interactions. Korean J Med Ethics 2011;14:193-201
10 Phillips ML, Kupfer DJ. Bipolar disorder diagnosis: challenges and future directions. Lancet 2013:381:1663-1671   DOI
11 Kuehn BM. APA targets unnecessary antipsychotic use. JAMA 2013; 310:1909-1910   DOI
12 Lopez OL, Becker JT, Olang YF, Sweet RA, Aizenstein H, Snitz B, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease, Am J Psychiatry 2013;170:1051-1058,   DOI
13 Tanne JH. US university psychiatrist loses chairmanship over drug company payments. BMJ 2009;338:3188.   DOI
14 Carpenter WT Jr, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, et al. Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 2000;57:533-538.   DOI
15 Kim SY, Caine ED, Currer GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research, Am J Psychiatry 2001;158:712-717.   DOI
16 Norris SL, Holmer HK, Ogden LA, Burda BU, Fu R. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: An observational study. BMC Med Ethics 2012;13:24.   DOI
17 Safer DJ Design and reporting modifications in industry sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002;190:583-592,   DOI
18 Otto MW, Nirenberg AA. Assay sensitivity, failed clinical trials and the conduct of science. Psychother Psychosom 2002;71:241-243   DOI
19 Meier B. Major medical journals will require registration oftrials. New York Times, Sep 9;2004. p. C11
20 Who.int [homepage Oil the internet]. Geneva: World Health Organization. international clinical trials registry platform. [cited 2015 Oct 1]. Available from:http://www.who.int/ictrp/en/
21 Helmchen H. Ethics of clinical research with mentally ill persons. Eur. Arch Psychiatry Clin Neurosci 2012;262:441-452.   DOI
22 이하영, 이민창. 의약품 리베이트 자율규제의 한계: 제도론적 접근. 행정논총 2011;49:149-150
23 Luborsky L, Diguer L, Seligman DA, Rosenthal R, Krause ED, Johnson S, et al. The researcher's own therapy allegiance: a "wild card" in comparisons of treatment efficacy, ClinPsychol Sci Pract 1999;6:95-106.
24 Kang MS, Koh YS. Management of conflicts of interest in physicianpharmaceutical industry Interaction. Korean J Med Ethics 2011;14:361-371.
25 Maj M. Financial and non-financial conflicts of interests in psychiatry. Eur. Arch. Psychiatry Clin. Neurosci 2010;260:S147-S151.   DOI
26 Maj M. Non-financial conflicts of interests in psychiatric research and practice. Br J Psychiatry 2008;193:91-92.   DOI
27 Hussain A, Smith R. Declaring financial competing interests: survey of five medical journals, BMJ 2001;323:263-264   DOI
28 International Committee of Medical Journals Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publications. Ann Intern Med 1997;126:36-47   DOI
29 Facs.org[homepage on the internet] Chicago: American College of Surgeon& Statements on Principles [updated 2008 Sep 1; cited 2015 Oct 1]. Available from:https://www.facs.org/about-acs/statements/stonprin